这是一篇来自已证抗体库的有关人类 CD39的综述，是根据35篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD39 抗体。
CD39 同义词: ATPDase; CD39; NTPDase-1; SPG64

其他
  • 流式细胞仪; 人类; 图 5
 CD39抗体（R&D Systems, clone 498403)被用于被用于流式细胞仪在人类样本上 (图 5). Sci Rep (2019) ncbi
BioLegend
小鼠 单克隆（A1）
  • mass cytometry; 人类; 图 s4a
BioLegend CD39抗体（Biolegend, 328221)被用于被用于mass cytometry在人类样本上 (图 s4a). Biomark Res (2022) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类; 1:100; 图 e4h
BioLegend CD39抗体（Biolegend, 328206)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 e4h). Nat Med (2021) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类; 图 s9b
BioLegend CD39抗体（Biolegend, 328226)被用于被用于流式细胞仪在人类样本上 (图 s9b). Science (2021) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类; 1:50
BioLegend CD39抗体（Biolegend, 328230)被用于被用于流式细胞仪在人类样本上浓度为1:50. bioRxiv (2020) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类; 1:250
BioLegend CD39抗体（BioLegend, 328226)被用于被用于流式细胞仪在人类样本上浓度为1:250. Nature (2020) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类; 图 s1a
BioLegend CD39抗体（Biolegend, 328212)被用于被用于流式细胞仪在人类样本上 (图 s1a). J Clin Invest (2019) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类; 图 2a
BioLegend CD39抗体（BioLegend, 328218)被用于被用于流式细胞仪在人类样本上 (图 2a). Cell Rep (2018) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类; 图 1a
BioLegend CD39抗体（Biolegend, 328202)被用于被用于流式细胞仪在人类样本上 (图 1a). Cell (2018) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类; 图 st12
BioLegend CD39抗体（Biolegend, A1)被用于被用于流式细胞仪在人类样本上 (图 st12). Science (2017) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类; 图 6d
BioLegend CD39抗体（BioLegend, A1)被用于被用于流式细胞仪在人类样本上 (图 6d). Cell Death Dis (2016) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类; 图 s8
BioLegend CD39抗体（BioLegend, A1)被用于被用于流式细胞仪在人类样本上 (图 s8). Science (2016) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类; 图 3i
BioLegend CD39抗体（BioLegend, A1)被用于被用于流式细胞仪在人类样本上 (图 3i). Sci Rep (2016) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 猕猴; 1:50
BioLegend CD39抗体（BioLegend, 328214)被用于被用于流式细胞仪在猕猴样本上浓度为1:50. Nat Med (2016) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类
BioLegend CD39抗体（BioLegend, A1)被用于被用于流式细胞仪在人类样本上. Am J Transplant (2016) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类; 图 S2,S3
BioLegend CD39抗体（biolegend, 328213)被用于被用于流式细胞仪在人类样本上 (图 S2,S3). PLoS Pathog (2015) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类
BioLegend CD39抗体（Biolegend, clone A1)被用于被用于流式细胞仪在人类样本上. Clin Vaccine Immunol (2015) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类; 表 s1
BioLegend CD39抗体（Biolegend, A1)被用于被用于流式细胞仪在人类样本上 (表 s1). PLoS ONE (2015) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类; 图 1
BioLegend CD39抗体（BioLegend, A1)被用于被用于流式细胞仪在人类样本上 (图 1). J Autoimmun (2015) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类; 图 1
BioLegend CD39抗体（BioLegend, A1)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2015) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 猕猴
BioLegend CD39抗体（Biolegend, A1)被用于被用于流式细胞仪在猕猴样本上. Clin Immunol (2014) ncbi
赛默飞世尔
小鼠 单克隆（eBioA1 (A1)）
  • 流式细胞仪; African green monkey; 图 s4
赛默飞世尔 CD39抗体（ebioscience, eBioA1)被用于被用于流式细胞仪在African green monkey样本上 (图 s4). Nature (2017) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类; 图 3b
赛默飞世尔 CD39抗体（eBioscience, A1)被用于被用于流式细胞仪在人类样本上 (图 3b). Clin Exp Immunol (2017) ncbi
小鼠 单克隆（eBioA1 (A1)）
  • 流式细胞仪; 人类; 图 2e
赛默飞世尔 CD39抗体（eBioscience, eBioA1)被用于被用于流式细胞仪在人类样本上 (图 2e). Am J Transplant (2017) ncbi
小鼠 单克隆（eBioA1 (A1)）
  • 流式细胞仪; 人类; 图 7b
赛默飞世尔 CD39抗体（eBioscience, 25-0399-42)被用于被用于流式细胞仪在人类样本上 (图 7b). Sci Rep (2016) ncbi
小鼠 单克隆（eBioA1 (A1)）
  • 流式细胞仪; 小鼠; 图 s1
赛默飞世尔 CD39抗体（eBioscience, A1)被用于被用于流式细胞仪在小鼠样本上 (图 s1). Nat Immunol (2015) ncbi
小鼠 单克隆（eBioA1 (A1)）
  • 流式细胞仪; 人类
赛默飞世尔 CD39抗体（eBioscience, eBioA1)被用于被用于流式细胞仪在人类样本上. Hum Immunol (2015) ncbi
小鼠 单克隆（eBioA1 (A1)）
  • 流式细胞仪; 人类; 图 s1b
赛默飞世尔 CD39抗体（eBioscience, 11-0399-42)被用于被用于流式细胞仪在人类样本上 (图 s1b). Oncotarget (2014) ncbi
小鼠 单克隆（A1）
  • 流式细胞仪; 人类; 1:10; 图 s6
赛默飞世尔 CD39抗体（Invitrogen, A1)被用于被用于流式细胞仪在人类样本上浓度为1:10 (图 s6). Nat Med (2013) ncbi
小鼠 单克隆（eBioA1 (A1)）
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD39抗体（eBioscience, eBio A1)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2010) ncbi
小鼠 单克隆（eBioA1 (A1)）
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD39抗体（eBioscience, 25-0399)被用于被用于流式细胞仪在人类样本上 (图 3). J Immunol (2009) ncbi
小鼠 单克隆（eBioA1 (A1)）
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD39抗体（eBioscience, eBioA1)被用于被用于流式细胞仪在人类样本上 (图 1). Clin Immunol (2010) ncbi
伯乐（Bio-Rad）公司
小鼠 单克隆（A1）
  • 抑制或激活实验; 人类; 10 ug/ml
伯乐（Bio-Rad）公司 CD39抗体（AbD serotec, A1)被用于被用于抑制或激活实验在人类样本上浓度为10 ug/ml. Oncoimmunology (2016) ncbi
艾博抗（上海）贸易有限公司
domestic rabbit 单克隆（EPR3678(2)）
  • 免疫印迹; 小鼠; 1:5000; 图 6b
艾博抗（上海）贸易有限公司 CD39抗体（Abcam, ab108248)被用于被用于免疫印迹在小鼠样本上浓度为1:5000 (图 6b). PLoS ONE (2017) ncbi
碧迪BD
小鼠 单克隆（TU66）
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD39抗体（BD, 560239)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
文章列表
  1. Jiang Z, Qin L, Tang Y, Liao R, Shi J, He B, et al. Human induced-T-to-natural killer cells have potent anti-tumour activities. Biomark Res. 2022;10:13 pubmed 出版商
  2. Spiegel J, Patel S, Muffly L, Hossain N, Oak J, Baird J, et al. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nat Med. 2021;27:1419-1431 pubmed 出版商
  3. Weber E, Parker K, Sotillo E, Lynn R, Anbunathan H, Lattin J, et al. Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling. Science. 2021;372: pubmed 出版商
  4. Mathew D, Giles J, Baxter A, Greenplate A, Wu J, Alanio C, et al. Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions. bioRxiv. 2020;: pubmed 出版商
  5. Gate D, Saligrama N, Leventhal O, Yang A, Unger M, Middeldorp J, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 2020;577:399-404 pubmed 出版商
  6. Muhammad F, Wang D, Montieth A, Lee S, Preble J, Foster C, et al. PD-1+ melanocortin receptor dependent-Treg cells prevent autoimmune disease. Sci Rep. 2019;9:16941 pubmed 出版商
  7. Finney O, Brakke H, Rawlings Rhea S, Hicks R, Doolittle D, López M, et al. CD19 CAR T cell product and disease attributes predict leukemia remission durability. J Clin Invest. 2019;129:2123-2132 pubmed 出版商
  8. Kim C, Hu B, Jadhav R, Jin J, Zhang H, Cavanagh M, et al. Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells. Cell Rep. 2018;25:2148-2162.e5 pubmed 出版商
  9. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed 出版商
  10. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed 出版商
  11. Villa Bellosta R, Hamczyk M, Andres V. Novel phosphate-activated macrophages prevent ectopic calcification by increasing extracellular ATP and pyrophosphate. PLoS ONE. 2017;12:e0174998 pubmed 出版商
  12. Nishimura Y, Gautam R, Chun T, Sadjadpour R, Foulds K, Shingai M, et al. Early antibody therapy can induce long-lasting immunity to SHIV. Nature. 2017;543:559-563 pubmed 出版商
  13. Jeffery H, Jeffery L, Lutz P, Corrigan M, Webb G, Hirschfield G, et al. Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. Clin Exp Immunol. 2017;188:394-411 pubmed 出版商
  14. Boardman D, Philippeos C, Fruhwirth G, Ibrahim M, Hannen R, Cooper D, et al. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection. Am J Transplant. 2017;17:931-943 pubmed 出版商
  15. Wei C, Mei J, Tang L, Liu Y, Li D, Li M, et al. 1-Methyl-tryptophan attenuates regulatory T cells differentiation due to the inhibition of estrogen-IDO1-MRC2 axis in endometriosis. Cell Death Dis. 2016;7:e2489 pubmed 出版商
  16. Sen D, Kaminski J, Barnitz R, Kurachi M, Gerdemann U, Yates K, et al. The epigenetic landscape of T cell exhaustion. Science. 2016;354:1165-1169 pubmed
  17. Jiang J, Chen X, An H, Yang B, Zhang F, Cheng X. Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling. Sci Rep. 2016;6:32320 pubmed 出版商
  18. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed 出版商
  19. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed 出版商
  20. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  21. Thibaudin M, Chaix M, Boidot R, Végran F, Derangère V, Limagne E, et al. Human ectonucleotidase-expressing CD25high Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions. Oncoimmunology. 2016;5:e1055444 pubmed
  22. Muller L, Mitsuhashi M, Simms P, Gooding W, Whiteside T. Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets. Sci Rep. 2016;6:20254 pubmed 出版商
  23. McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C, et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914 pubmed 出版商
  24. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed 出版商
  25. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed 出版商
  26. Wensveen F, Jelenčić V, Valentić S, Å estan M, Wensveen T, Theurich S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16:376-85 pubmed 出版商
  27. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed 出版商
  28. Bhela S, Kempsell C, Manohar M, Dominguez Villar M, Griffin R, Bhatt P, et al. Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6. J Immunol. 2015;194:2180-9 pubmed 出版商
  29. Rueda C, Wells C, Gisslen T, Jobe A, Kallapur S, Chougnet C. Effect of chorioamnionitis on regulatory T cells in moderate/late preterm neonates. Hum Immunol. 2015;76:65-73 pubmed 出版商
  30. Ye S, Li Z, Luo D, Huang B, Chen Y, Zhang X, et al. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget. 2014;5:5439-52 pubmed
  31. Demberg T, Mohanram V, Venzon D, Robert Guroff M. Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model. Clin Immunol. 2014;153:264-76 pubmed 出版商
  32. Park S, Veerapu N, Shin E, Biancotto A, McCoy J, Capone S, et al. Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. Nat Med. 2013;19:1638-42 pubmed 出版商
  33. Oo Y, Weston C, Lalor P, Curbishley S, Withers D, Reynolds G, et al. Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J Immunol. 2010;184:2886-98 pubmed 出版商
  34. Brucklacher Waldert V, Steinbach K, Lioznov M, Kolster M, Holscher C, Tolosa E. Phenotypical characterization of human Th17 cells unambiguously identified by surface IL-17A expression. J Immunol. 2009;183:5494-501 pubmed 出版商
  35. Cernea S, Herold K. Monitoring of antigen-specific CD8 T cells in patients with type 1 diabetes treated with antiCD3 monoclonal antibodies. Clin Immunol. 2010;134:121-9 pubmed 出版商